In addition to the hotspot mutation in the PLEKHS1 promoter region as described above, its mutations in encoding sequences are also identified in bladder cancer and other malignancies [17,23,25]; and these mutations can be missense, truncating or inframe shifting. Here, PLEKHS1 is linked to urinary bladder carcinoma.